Lyn tyrosine kinase regulates androgen receptor expression and activity in castrate-resistant prostate cancer

Castrate-resistant prostate cancer (CRPC) progression is a complex process by which prostate cells acquire the ability to survive and proliferate in the absence or under very low levels of androgens. Most CRPC tumors continue to express the androgen receptor (AR) as well as androgen-responsive genes...

Descripción completa

Detalles Bibliográficos
Autores principales: Zardan, A, Nip, K M, Thaper, D, Toren, P, Vahid, S, Beraldi, E, Fazli, L, Lamoureux, F, Gust, K M, Cox, M E, Bishop, J L, Zoubeidi, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5189960/
https://www.ncbi.nlm.nih.gov/pubmed/25133482
http://dx.doi.org/10.1038/oncsis.2014.30

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5189960/
https://www.ncbi.nlm.nih.gov/pubmed/25133482
http://dx.doi.org/10.1038/oncsis.2014.30

Ejemplares similares